Peregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the Tape
January 07 2014 - 8:57AM
Zacks
Peregrine Pharmaceuticals,
Inc. (PPHM) was a big mover last session, as the company
saw its shares rise over 14% on the day. The move came on solid
volume too with far more shares changing hands than in a normal
session. This continues the recent uptrend for the company as the
stock is now up nearly 24% in the past one-month time frame.
The company has seen a mixed track record. There has been one
upward revision and one downward revision over the past 30 days,
while the Zacks Consensus Estimate has not been in a trend either.
Yesterday’s price jump is encouraging though, so make sure to keep
a close watch on this firm in the near future.
Peregrine Pharmaceuticals currently has a Zacks Rank #3 (Hold)
while its Earnings ESP is 0.00%.
However, better-ranked stocks in the biomedicine/gene medical
industry include Aastrom Biosciences, Inc.
(ASTM), Gentium S.p.A
(GENT) and Heska Corp.
(HSKA). All these carry a Zacks Rank #1 (Strong
Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download 7 Best Stocks for the Next 30
Days. Click to get this free report >>
AASTROM BIOSCI (ASTM): Get Free Report
GENTIUM SPA-ADR (GENT): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
PEREGRINE PHARM (PPHM): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vericel (NASDAQ:VCEL)
Historical Stock Chart
From Sep 2023 to Sep 2024